H. J. Res. 54, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions

• This item is from the 110th Congress (2007-2008) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.

H. J. Res. 54 would provide for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.

(read more ↓)